Trimodal Therapy a Potential Alternative to Radical Cystectomy MD Bureau30 April 2022 3:30 AM GMTRadical cystectomy (RC) has long been the standard of care for the management of muscle-invasive bladder cancer (MIBC). However, an increasing trend...
Prophylactic Compression Sleeves reduces Breast Cancer-Related Lymphedema; ASCO Medical Dialogues Editorial Team11 March 2022 3:30 AM GMTIn women at high risk for lymphedema, prophylactic usage of compression sleeves reduced and delayed the emergence of arm swelling in the first year...
Breast cancer survivors at increased risk of diabetes and hypertension: ASCO Medical Dialogues Editorial Team5 March 2022 3:30 AM GMTUSA: In a new study conducted by Marilyn L. Kwan and team, it was found that breast cancer (BC) survivors at Kaiser Permanente Northern California...
Bupropion of no significant benefit for enhancing sexual desire in cancer survivors: Study Medical Dialogues Editorial Team18 Jan 2022 3:45 AM GMTUSA: Bupropion was not more beneficial than placebo in enhancing the Female Sexual Function Index (FSFI) desired subscale, according to a recent study...
Immunotherapy drug shows promise in advanced endometrial cancer Hina Zahid10 Jan 2022 3:30 AM GMTCOLUMBUS, Ohio - A cancer immunotherapy drug currently approved by the U.S. Food and Drug Administration (FDA) to treat several forms of cancer is...
Abiraterone acetate helps with better quality of life than Docetaxel in Prostate Cancer: ASCO Medical Dialogues Editorial Team4 Jan 2022 3:30 AM GMTIn a new research done by Hannah L Rush and colleagues, it was shown that during a 2-year period, patient-reported QOL was superior for patients...
Nivolumab and Ipilimumab combo bests monotherapy in improving clinical outcomes in Advanced Melanoma MD Editorial Team17 Dec 2021 3:30 AM GMTIn a new study CheckMate 067, the results demonstrated durable, improved clinical outcomes with nivolumab plus ipilimumab or nivolumab versus...
ASCO guideline on prevention and management of chemotherapy-induced PN in cancer survivors Medha Baranwal23 Nov 2021 1:30 PM GMTUSA: The American Society of Clinical Oncology (ASCO) has released an updated guideline on the prevention and management of chemotherapy-induced...
Prevention of Xerostomia and salivary gland hypofunction induced by nonsurgical cancer therapies: Updated guidelines Medha Baranwal24 Aug 2021 3:30 AM GMTUSA: Multinational Association of Supportive Care in Cancer/International Society of Oral Oncology (MASCC/ISOO) and ASCO have released a new guideline...
Sacituzumab govitecan, promising treatment option for advanced urothelial cancer: Phase 2 trial Hina Zahid7 Aug 2021 3:30 AM GMTUSA: A new treatment called sacituzumab govitecan (SG) is effective with tolerable side effects in patients with advanced urothelial cancer, show...
Early postoperative radiation therapy reduces mortality in high risk prostate cancer patients: Study Hina Zahid7 Jun 2021 3:30 AM GMT"Men at the highest risk for dying from prostate cancer may lose the chance for cure if we wait for the PSA to become measurable before delivering...
Dyspnea management in advanced cancer: ASCO Guideline Medha Baranwal26 Feb 2021 11:15 AM GMTUSA: The American Society of Clinical Oncology (ASCO) has released guideline on clinical management of dyspnea in adult patients with advanced cancer....
